JSMO Japanese Society of Medical Oncology

Contact USSearchen

SearchInput the word you want to find

  • HOME
  • ABOUT JSMO
  • 2018 Award Recipients

2018 Award Recipients

2018 Award Recipients

Annals of Oncology Award
Name Affiliation Awarded Paper
Kaoru Kubota Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School

A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

Annals of Oncology, Volume 26, Issue 7, 1 July 2015, Pages 1401-1408,

Young Investigator Award
Name Affiliation Title
Yoshinori Imamura Department of Medical Oncology and Hematology, Kobe University Hospital Docetaxel plus Cisplatin in Recurrent and/or Metastatic Non-squamous Cell Carcinoma of Head and Neck: a Phase II Trial
Kazunori Honda Department of Clinical Oncology, Aichi Cancer Center Hospital A prospective survey of COmprehensive Score for financial Toxicity (COST) in Japanese cancer patients
Koji Haratani Department of Medical Oncology, Kindai University Faculty of Medicine Tumor immune microenvironment and prognosis of cancer of unknown primary
Yusuke Kanemasa Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma
Jumpei Takeshita Genome Science Division, Research Center for Advanced Science and Technology, the University of Tokyo Comprehensive molecular characterization of malignant pleural mesothelioma
Kei Kunimasa Department of Thoracic Oncology, Osaka International Cancer Institute Immuno-oncology biomarker study in a large cohort of LC-SCRUM-Japan:LC-SCRUM-IBIS
Jia Wei The Comprehensive Cancer
Centre of Drum Tower Hospital,
Medical School of Nanjing
University & Clinical Cancer
Institute of Nanjing University
Targeted-sequencing and comprehensive molecular profiling of gastric signet ring cell carcinoma
Musadiq Ahmad Bhat maulana azad medical college Aberrant promoter methylation ofcell cycle genes is associated with disease progression and molecular response CMLpatients

※Titles omitted, listed in Japanese alphabetical order.

※Affiliations are listed as of the time of the award.

Scenes from the Award Ceremony

Scenes from the Award Ceremony1Scenes from the Award Ceremony2Scenes from the Award Ceremony3

※Click to view a larger image.